CareRx Statistics

Total Valuation

CareRx has a market cap or net worth of CAD 173.17 million. The enterprise value is 246.72 million.

Market Cap	173.17M
Enterprise Value	246.72M

Important Dates

The next estimated earnings date is Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	n/a

Share Statistics

CareRx has 62.74 million shares outstanding. The number of shares has increased by 5.06% in one year.

Current Share Class	n/a
Shares Outstanding	62.74M
Shares Change (YoY)	+5.06%
Shares Change (QoQ)	+1.41%
Owned by Insiders (%)	1.82%
Owned by Institutions (%)	34.51%
Float	30.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.47
PB Ratio	2.06
P/TBV Ratio	n/a
P/FCF Ratio	5.34
P/OCF Ratio	4.56
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.56, with an EV/FCF ratio of 7.61.

EV / Earnings	-54.81
EV / Sales	0.67
EV / EBITDA	9.56
EV / EBIT	36.39
EV / FCF	7.61

Financial Position

The company has a current ratio of 0.99, with a Debt / Equity ratio of 0.98.

Current Ratio	0.99
Quick Ratio	0.67
Debt / Equity	0.98
Debt / EBITDA	3.20
Debt / FCF	2.55
Interest Coverage	0.76

Financial Efficiency

Return on equity (ROE) is -5.43% and return on invested capital (ROIC) is 2.45%.

Return on Equity (ROE)	-5.43%
Return on Assets (ROA)	1.86%
Return on Invested Capital (ROIC)	2.45%
Return on Capital Employed (ROCE)	4.22%
Revenue Per Employee	250,146
Profits Per Employee	-3,070
Employee Count	1,508
Asset Turnover	1.61
Inventory Turnover	13.86

Taxes

Income Tax	-440,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +16.95% in the last 52 weeks. The beta is 0.53, so CareRx's price volatility has been lower than the market average.

Beta (5Y)	0.53
52-Week Price Change	+16.95%
50-Day Moving Average	2.67
200-Day Moving Average	2.23
Relative Strength Index (RSI)	56.58
Average Volume (20 Days)	7,972

Short Selling Information

The latest short interest is 865, so 0.00% of the outstanding shares have been sold short.

Short Interest	865
Short Previous Month	1,548
Short % of Shares Out	0.00%
Short % of Float	0.00%
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CareRx had revenue of CAD 366.71 million and -4.50 million in losses. Loss per share was -0.07.

Revenue	366.71M
Gross Profit	108.06M
Operating Income	6.78M
Pretax Income	-4.47M
Net Income	-4.50M
EBITDA	22.06M
EBIT	6.78M
Loss Per Share	-0.07

Full Income Statement

Balance Sheet

The company has 9.08 million in cash and 82.63 million in debt, giving a net cash position of -73.55 million or -1.17 per share.

Cash & Cash Equivalents	9.08M
Total Debt	82.63M
Net Cash	-73.55M
Net Cash Per Share	-1.17
Equity (Book Value)	84.23M
Book Value Per Share	1.36
Working Capital	-467,000

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 37.99 million and capital expenditures -5.59 million, giving a free cash flow of 32.40 million.

Operating Cash Flow	37.99M
Capital Expenditures	-5.59M
Free Cash Flow	32.40M
FCF Per Share	0.52

Full Cash Flow Statement

Margins

Gross margin is 29.47%, with operating and profit margins of 1.85% and -1.23%.

Gross Margin	29.47%
Operating Margin	1.85%
Pretax Margin	-1.22%
Profit Margin	-1.23%
EBITDA Margin	6.02%
EBIT Margin	1.85%
FCF Margin	8.84%

Dividends & Yields

CareRx does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.06%
Shareholder Yield	-5.06%
Earnings Yield	-2.60%
FCF Yield	18.71%

Stock Splits

The last stock split was on June 25, 2020. It was a reverse split with a ratio of 0.05.

Last Split Date	Jun 25, 2020
Split Type	Reverse
Split Ratio	0.05

Scores

CareRx has an Altman Z-Score of 0.46 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.46
Piotroski F-Score	4